drugset / Trial / NCT04433390
Effect of Naloxegol on Postoperative Ileus in Patients Undergoing Cardiac Surgery
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Postoperative ileus, defined as the transient postoperative functional inhibition of propulsive bowel activity, commonly occurs in patients after cardiac surgery and contributes to postoperative morbidity. Naloxegol is a peripheral opioid receptor antagonist. Recent studies showed that naloxegol is effective in the treatment of chronic opioid-induced constipation but there is no data on its use in the management of postoperative ileus after cardiac surgery. The main objective of this prospective, double-blind, randomized, placebo-controlled trial is to assess the effectiveness of the perioperative use of naloxegol in reducing the duration of the postoperative ileus in patients undergoing cardiac surgery.
Timeline
- Start
- 2020-10-14
- Primary completion
- 2022-01-28
- Completion
- 2022-03-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naloxegol | Small molecule | 25 mg | Oral |